RA
ABBV icon

Riverstone Advisors’s AbbVie ABBV Stock Holding History

Riverstone Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$527K Buy
2,094
+322
+18% +$69.3K 0.22% 41
2026
Q1 		$385K Buy
1,772
+111
+7% +$24.6K 0.19% 45
2025
Q4 		$380K Buy
1,661
+305
+22% +$69.5K 0.18% 41
2025
Q3 		$314K Buy
1,356
+3
+0.2% +$611 0.15% 46
2025
Q2 		$251K Buy
1,353
+3
+0.2% +$558 0.14% 52
2025
Q1 		$283K Buy
1,350
+2
+0.1% +$389 0.17% 41
2024
Q4 		$240K Buy
1,348
+3
+0.2% +$552 0.14% 45
2024
Q3 		$266K Buy
1,345
+2
+0.1% +$373 0.15% 38
2024
Q2 		$230K Buy
1,343
+3
+0.2% +$497 0.14% 40
2024
Q1 		$244K Buy
1,340
+3
+0.2% +$517 0.15% 38
2023
Q4 		$207K Buy
+1,337
New +$195K 0.13% 47

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Riverstone Advisors's ABBV Position: Q2 2026 in Review

Riverstone Advisors increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $69.3K and bringing the position to 2,094 shares worth $527K. The position accounts for 0.22% of the portfolio, ranked #41.

Riverstone Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Riverstone Advisors held 2,094 shares of AbbVie worth $527K as of Q2 2026.
  • Riverstone Advisors bought 322 AbbVie shares in Q2 2026, an estimated $69.3K.
  • AbbVie made up 0.22% of Riverstone Advisors's portfolio in Q2 2026, its #41 holding.
  • Riverstone Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Riverstone Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.